so for a doctor in the ward, for patients post hip fractures, need bone health plan in uk, tell me about how to formulate bone health plan in detail and how to counsel patients in detail

Reading File
Finding Sources
Finding Sources
Searching PubMed

"hip fracture" AND "bone health" AND "secondary prevention" AND "United Kingdom"

Searching the Web

UK bone health plan post hip fracture ward guidelines NICE SIGN 2024 2025

Finding Sources
Finding Sources
Reading Web Page

bone health plan post hip fracture osteoporosis treatment counselling UK

Searching PubMed

"hip fracture" AND "osteoporosis" AND "secondary prevention"

Finding Sources
Reading Article
Reading Article
Searching the Web

NOGG 2024 guidelines osteoporosis hip fracture treatment alendronate zoledronate denosumab UK

Reading Web Page

post hip fracture bone health plan treatment counselling patient ward inpatient UK NOGG FLS

Finding Sources
Finding Sources
Reading File
Searching the Web

fracture liaison service FLS hip fracture inpatient bone health counselling patient education UK 2024 2025

I now have comprehensive information from the NOGG 2024 guidelines, Nottinghamshire APC local guidelines, NHFD 2025, and recent systematic reviews. Let me compile the full clinical guide.

Bone Health Plan Post-Hip Fracture: A Ward Doctor's Guide (UK, 2026)

Context and Rationale

Over 70,000 hip fractures occur annually in England, Wales and Northern Ireland. A quarter of these patients will sustain another fragility fracture. The immediate post-fracture period is the window of highest imminent re-fracture risk - more than one-third of subsequent fractures over a 10-year period occur within the first year after the index fracture (NOGG 2024, Evidence level Ic). Yet prescription rates for anti-osteoporosis medication (AOM) remain inadequate. This makes the ward admission the most important opportunity to initiate secondary prevention.

Part 1: Formulating the Bone Health Plan

Step 1: Identify the Patient - Who Needs a Plan?

All patients aged ≥50 years admitted with a hip fracture should receive a bone health plan. Hip fracture in this age group is treated as a very high-risk fragility fracture by NOGG 2024, which means:
  • No prior DXA scan is required before initiating treatment
  • FRAX can be used to quantify 10-year risk but do not delay treatment waiting for it
  • Start treatment promptly - imminent risk is highest in the days and weeks after the fracture

Step 2: Clinical Assessment

History - identify secondary causes and risk factors:
  • Age, sex, menopausal status (women) / hypogonadism (men)
  • Prior fragility fractures (spine, wrist, hip, humerus)
  • Parental hip fracture history
  • Corticosteroid use (≥7.5 mg prednisolone/day for ≥3 months)
  • Alcohol intake (≥3 units/day is a risk factor)
  • Smoking (current or ex)
  • Rheumatoid arthritis
  • Secondary osteoporosis causes: hyperthyroidism, hyperparathyroidism, chronic liver disease, coeliac disease, inflammatory bowel disease, chronic kidney disease, hypogonadism, prolonged immobility
  • Falls history: number of falls in past year, circumstances, dizziness/syncope, visual problems
  • Medications contributing to falls: antihypertensives, diuretics, benzodiazepines, antipsychotics, antidepressants, opioids, antiepileptics
  • Review medications increasing fracture risk: long-term steroids, proton pump inhibitors, SSRIs, antiepileptics, thiazolidinediones, androgen deprivation therapy, aromatase inhibitors
Examination:
  • Height (ideally compared to historical height - >4 cm loss suggests vertebral fractures)
  • Body weight / BMI (low BMI <19 kg/m² is a risk factor)
  • Kyphosis (vertebral fractures)
  • Gait, balance, functional assessment
  • Cognitive assessment (affects adherence counselling)
  • Dental assessment history (relevant before bisphosphonate/denosumab)

Step 3: Investigations

Routine bloods (to rule out secondary causes and check renal function before drug choice):
TestPurpose
FBCMalnutrition, haematological malignancy
U&E, eGFR/CrClGuides drug choice (bisphosphonates need adequate renal function)
LFTsLiver disease
Adjusted calciumHypercalcaemia (malignancy), hypocalcaemia (must correct before treatment)
PhosphateOsteomalacia
Alkaline phosphatasePaget's disease, liver disease
25-OH Vitamin DDeficiency is common; correct before bisphosphonates/denosumab
TSHHyperthyroidism
Testosterone (men)Hypogonadism
PTHHyperparathyroidism
Serum protein electrophoresisMyeloma
ESR/CRPInflammatory disease
Imaging:
  • Lateral spine X-ray (or VFA on DXA) to identify morphometric vertebral fractures - these may be asymptomatic but increase fracture risk further and change treatment category
  • DXA scan: Request at admission or as an outpatient. For post-hip fracture, treatment is initiated regardless of DXA result, but DXA:
    • Provides baseline for treatment monitoring
    • Confirms T-score (may influence choice between oral vs. IV bisphosphonate)
    • Identifies vertebral fractures on VFA
    • A T-score ≤ -3.5 or multiple vertebral fractures should trigger specialist referral
FRAX calculation:
  • Use the Sheffield FRAX tool (frax.shef.ac.uk) with BMD input if available
  • For post-hip fracture patients ≥50 years, FRAX will virtually always indicate high/very high risk
  • If DXA not practical (frailty, age >89), use FRAX without BMD and NOGG intervention thresholds
  • Repeat FRAX after any new fracture, regardless of when the last one was done

Step 4: Risk Stratification Using NOGG 2024

Post-hip fracture patients automatically fall into the high or very high risk category:
CategoryDefinitionAction
High riskPrior hip or vertebral fracture, FRAX above intervention thresholdStart oral bisphosphonate (first line)
Very high riskHip fracture + T-score ≤ -3.5, multiple vertebral fractures, fracture on treatment, CrCl <30 mL/min, recent (within 2 years) vertebral fractureRefer to bone specialist for consideration of anabolic therapy or IV/SC treatment; start oral bisphosphonate in the meantime if no contraindication

Step 5: Correct Deficiencies Before Starting Bone Treatment

Vitamin D:
  • Check 25-OH vitamin D level
  • If deficient (<25 nmol/L): loading dose (e.g. 300,000 IU colecalciferol over 6-10 weeks), then maintenance
  • If insufficient (25-50 nmol/L): standard loading or start maintenance directly
  • Maintenance: 800-2000 IU colecalciferol daily (NOGG/NICE recommendation)
  • Do not start bisphosphonates or denosumab with uncorrected vitamin D deficiency - risk of severe hypocalcaemia
Calcium:
  • Aim for total intake 700-1200 mg/day (diet + supplement)
  • Check dietary intake first - many patients only need a modest supplement
  • Typical supplement: calcium carbonate 500-1000 mg daily if diet is insufficient
  • Do not over-supplement: calcium supplements alone show limited benefit on fracture prevention and excessive intake carries cardiovascular concerns

Step 6: Pharmacological Treatment

First-Line Choices (per NOGG 2024 and Nottinghamshire/local NHS guidelines)

1. Alendronic acid 70 mg once weekly (oral)
  • First line for most patients
  • Requires CrCl ≥35 mL/min
  • Must be taken on an empty stomach with a full glass of water (200 mL), sitting/standing upright for 30 minutes, no food/drink/other medication for 30 minutes after
  • Contraindications: oesophageal abnormalities (stricture, achalasia), inability to sit/stand upright for 30 minutes, hypocalcaemia, CrCl <35 mL/min
  • Duration: plan for at least 5 years, reassess at 5 years; for post-hip fracture patients age ≥70 or with prior vertebral fractures, continue for at least 6-10 years before considering drug holiday
2. Risedronate 35 mg once weekly (oral)
  • Second line if alendronate not tolerated
  • Requires CrCl ≥30 mL/min
  • Same administration instructions as alendronate
3. Zoledronic acid (Zoledronate) 5 mg IV annually - important ward option
  • Strongly preferred post-hip fracture in many UK centres (Nottinghamshire, SIGN guidance) because:
    • Eliminates adherence issues (single annual infusion)
    • The HORIZON trial showed 35% reduction in hip fractures, 70% reduction in vertebral fractures
    • Can be given inpatient or as outpatient infusion (within ~2 weeks of surgery, ideally after the patient is mobile)
    • Wait 2 weeks post-operatively to give the first infusion (avoids acute phase reaction; also IV route preferred over oral in the immediate post-surgical period)
    • Requires CrCl ≥35 mL/min (use 5 mg dose for osteoporosis; note: 4 mg used off-label in some centres for hip fracture per local consensus)
    • Common side effect: acute phase reaction (flu-like illness, fever, myalgia, arthralgia) 1-3 days after first infusion; warn patients; resolves within 72 hours; pre-medication with paracetamol/ibuprofen reduces severity
    • Requires adequate hydration before infusion
    • Duration: at least 3 doses (3 years), then reassess; for post-hip fracture age ≥70, prior vertebral fracture, or ongoing steroids: extend to 6 years
    • Off-label extended interval: up to 18 months between doses in selected low-risk patients (on specialist advice only - not for hip fracture patients)

When to Refer to Bone Specialist (Rheumatology/Endocrinology/Metabolic Bone Clinic)

Refer all patients with:
  • BMD T-score ≤ -3.5
  • Recent (within 2 years) vertebral fractures Grade 2/3, or multiple vertebral fractures
  • Hip fracture (these should all be referred per Nottinghamshire APC v3.4, March 2026)
  • CrCl <30 mL/min and bone treatment indicated
  • Fracture despite good adherence to oral bisphosphonate for >12 months
  • Intolerance/contraindication to bisphosphonates
  • Need for anabolic therapy consideration
While awaiting specialist review, start an oral bisphosphonate if no contraindication - do not leave the patient unprotected.

Second/Specialist-Line Drugs

DrugRouteIndicationNotes
Denosumab 60 mg SC every 6 monthsSC injectionCrCl <30 mL/min, intolerance/failure of bisphosphonatesNo renal dose adjustment needed; do not stop abruptly - rapid rebound vertebral fracture risk; must transition to bisphosphonate if stopped
Teriparatide 20 mcg SC dailySC injectionVery high risk, multiple vertebral fractures, treatment failureLicensed for 24 months; must follow with antiresorptive (alendronate/zoledronate/denosumab)
Romosozumab 210 mg SC monthly x 12 monthsSC injectionVery high risk of vertebral fracture; NICE approved specific criteriaBlack box warning: do not use in patients at risk of MI or stroke; follow with antiresorptive
Ibandronate 150 mg monthly oralOralAlternative if weekly bisphosphonate not toleratedLess data for hip fracture; CrCl ≥30 mL/min
HRTOral/transdermalPostmenopausal women ≤60 yearsAlso benefits menopausal symptoms

Special Situations

Renal impairment:
  • CrCl 30-35 mL/min: risedronate preferred (CrCl ≥30 mL/min)
  • CrCl <30 mL/min: denosumab (no dose adjustment), with caution; refer specialist
Swallowing difficulties/upper GI problems:
  • Zoledronate IV or denosumab SC are preferred
Cognitive impairment/frailty:
  • IV zoledronate strongly preferred - ensures treatment delivery
  • Consider life expectancy and patient values carefully - initiate bone treatment if life expectancy >12 months
Men post-hip fracture:
  • NOGG 2024 applies to men aged ≥50 years - same pathway
  • Check testosterone levels
  • Alendronate and zoledronate are licensed in men

Step 7: Falls Risk Assessment and Prevention

This is an integral part of the bone health plan - treat falls and bone fragility together.
In-hospital:
  • Delirium assessment and management
  • Review and rationalise fall-risk medications (benzodiazepines, antipsychotics, antihypertensives, antiepileptics, opioids)
  • Physiotherapy referral for mobility and strength assessment
  • Occupational therapy for functional independence and home assessment
  • Visual assessment (refer ophthalmology if cataracts/visual impairment)
On discharge:
  • Refer to community falls prevention programme (NICE CG161)
  • Tai chi / structured exercise
  • Home hazard removal
  • Footwear advice
  • Hip protectors in care home residents

Step 8: Fracture Liaison Service (FLS)

Every patient with a hip fracture should be referred to the local FLS (NOGG 2024, Strong recommendation; NHFD 2025 requirement).
The FLS is a multidisciplinary, coordinator-based service that:
  • Ensures fracture and falls risk assessment
  • Initiates/oversees bone protection
  • Coordinates with primary care
  • Follow-up at 16 weeks and 52 weeks post-fracture (NOGG recommendation)
  • Monitors: medication adherence, calcium/vitamin D status, new fractures, side effects
Where an FLS is in place, treatment initiation rates increase by an average of 44% (systematic review, Hosseinzadeh 2026, PMID 41653468). The NHFD 2025 report notes that at least half of all patients should be on injectable bone protection at 4 months post-hip fracture.
If no FLS locally: Write clear instructions in the discharge summary for GP to:
  • Follow up at 4 and 12 months
  • Review medication adherence and fracture risk
  • Ensure calcium and vitamin D adequacy
  • Calculate/repeat FRAX after any new fracture

Part 2: Patient Counselling

Framework: The Two-Step Process

Research (de Jong-Holthuijsen 2025 systematic review, PMID 40838777) identifies that AOM initiation depends on two steps: addressing treatment (the doctor's initiative) and discussing treatment (shared decision-making with the patient). Both steps are needed - low prescription rates often reflect failure at one or both stages.

Step 1: Set the Stage - Timing and Environment

  • Have the conversation within the first 24-48 hours of admission once pain is controlled and delirium (if present) has been treated
  • If the patient has cognitive impairment, involve the next of kin/lasting power of attorney
  • Use plain language; avoid jargon
  • Ask about prior knowledge: "Has anyone ever talked to you about osteoporosis or bone thinning?"
  • A follow-up written information sheet (ROS 'Strong, Steady and Straight' booklet or similar) reinforces verbal counselling

Step 2: Explain Why Bone Health Matters (The "So What" Conversation)

Use simple, direct language:
"Your hip broke because of a condition called osteoporosis - thin, fragile bones. This is very common as we get older. The important thing is that we can treat it and significantly reduce the chance of you breaking another bone. If we don't treat it, you have a high chance - around 1 in 3 - of breaking another bone in the first year. With treatment, we can cut that risk substantially."
Key points to cover:
  • This is a medical condition, not a failure - fragility fractures are not just the result of a bad fall
  • Osteoporosis is treatable and common - it affects 1 in 3 women and 1 in 5 men in their lifetime
  • Post-hip fracture = high imminent risk of the next fracture, which may be more disabling
  • Treatment is long-term but effective

Step 3: Explain Calcium and Vitamin D

"The first thing we'll give you are supplements - vitamin D and calcium. Vitamin D helps your bones absorb calcium properly. Most people in the UK don't get enough sunlight to make enough vitamin D, especially in winter. Low vitamin D also weakens muscles and increases the risk of falls. These supplements alone aren't enough to stop further fractures, but they're the foundation of everything else."
  • Calcium: explain dietary sources first (dairy, leafy greens, fortified foods); supplement only the gap
  • Vitamin D: 800-2000 IU daily (maintenance); explain that sunlight exposure in the UK is insufficient for most of the year
  • Reassure these are well-tolerated and inexpensive

Step 4: Explain Bone Protection Medication

If alendronate is chosen:
"We're also going to start a bone-strengthening tablet called alendronic acid. This works by slowing down the natural breakdown of bone that happens as we age. It has been shown to halve the risk of further spine fractures and significantly reduce hip fracture risk."
Administration counselling - this is critical for safety and effectiveness:
"This tablet is taken once a week, on the same day each week. It must be taken on an empty stomach, first thing in the morning, with a large glass of plain water - at least 200 ml, about a full cup. You must sit or stand upright for at least 30 minutes after taking it - no lying down. Don't eat, drink, or take any other tablets for 30 minutes after. Taking it incorrectly can cause irritation to the food pipe."
Side effects to warn about:
  • Oesophageal irritation: chest pain, difficulty swallowing - if this occurs, stop and contact their GP or go to A&E
  • Flu-like illness with first dose (mainly IV zoledronate): fever, muscle aches, joint pains - usually mild and resolves within 72 hours; take paracetamol regularly for the first 48-72 hours
  • Jaw problems (osteonecrosis of jaw - ONJ): very rare with oral bisphosphonates (much less common than with high-dose IV for cancer treatment); good dental hygiene reduces risk; advise patient to inform dentist they are on bisphosphonates before any dental extraction - but do not let fear of ONJ prevent treatment
  • Atypical femoral fracture: very rare (around 1 in 100,000 patient-years); if thigh, groin, or hip pain develops between fracture events, report to GP promptly
If zoledronate is chosen (preferred in many ward situations):
"Instead of a weekly tablet, we can give you a once-yearly infusion through a drip. This has the advantage that you don't need to remember to take a tablet every week. It's equally effective and the evidence is very good. The first infusion might cause flu-like symptoms for a day or two - we'll give you paracetamol to take for the first couple of days just in case."
If denosumab is prescribed:
"This is a twice-yearly injection under the skin. It's particularly useful if your kidneys don't tolerate the other medications. One important thing: this medication must not be stopped abruptly - if you ever want to stop it, it must be done in consultation with your doctor who will transition you to a different bone medication. Stopping suddenly can cause a sudden risk of spinal fractures."

Step 5: Address Common Concerns

ConcernHow to address
"I've heard these tablets damage your jaw"ONJ is extremely rare with osteoporosis doses (much rarer than with cancer doses); good dental hygiene is key; inform your dentist; benefits far outweigh risks
"I'm too old / it won't make a difference"Studies show benefit even in patients in their 80s and 90s; the aim is to prevent the next fracture that may put you in a care home or cause premature death
"I don't want to take tablets for life"We review every 3-5 years; some patients can take a break after 5-6 years once the bone is stronger; we monitor this
"My friend took this and had problems"Serious side effects are rare; far rarer than the harm caused by another fracture; we monitor you carefully
"Will this fix my bones?"It won't cure osteoporosis but it significantly reduces the chance of the next break and helps prevent further bone loss
"I don't like injections" (for denosumab/zoledronate)There are oral tablet options; discuss the trade-off
"I already take too many tablets"Zoledronate (annual infusion) removes a daily/weekly medication burden

Step 6: Lifestyle and Non-Pharmacological Counselling

Diet:
  • Protein intake: aim above the RDA of 0.75 g/kg/day - important for bone and muscle (higher protein is associated with better hip BMD per NOGG 2024)
  • Calcium-rich foods: dairy (200 mL milk ~240 mg Ca), fortified plant milks, sardines with bones, leafy greens
  • Reduce alcohol: ≤2 units/day recommended; more than 3 units/day is an independent fracture risk factor
  • Maintain healthy weight: low BMI (<19) increases fracture risk
Exercise:
"Exercise is one of the most important things you can do for your bones and your balance. We're not talking about running - the right kinds of exercise are weight-bearing activities like walking, dancing, and climbing stairs, combined with muscle-strengthening exercises like using resistance bands or light weights. Balance training like tai chi has also been shown to reduce falls. Once you've recovered from surgery, aim for at least 150 minutes of moderate activity per week."
Smoking:
  • Current smoking increases fracture risk and impairs fracture healing
  • Offer smoking cessation support (refer to Stop Smoking services)
Sunlight/vitamin D:
  • Brief sun exposure (arms and face, ~15 minutes) during summer months
  • In winter (October-March in the UK), sun is insufficient; supplements are essential

Step 7: Falls Prevention Counselling

"Preventing falls is just as important as strengthening your bones. Some of the things we can help with include: a review of any medications that might make you dizzy or unsteady; an assessment of your home to remove trip hazards; physiotherapy to improve your strength and balance; and a referral to a falls prevention programme in your local community."
Practical points:
  • Non-slip footwear, well-fitted shoes
  • Adequate lighting in home, especially at night
  • Grab rails/handrails on stairs
  • Removal of loose rugs, trailing cables
  • Night lights for bathroom trips
  • Vision check (cataracts double fall risk)
  • In care home residents: hip protectors

Step 8: Discharge Planning and Follow-up

The discharge summary must include:
  1. Diagnosis of osteoporosis (or osteopenia if relevant) - code this explicitly
  2. Blood results and any pending investigations (DXA, bloods)
  3. Medications started (with administration instructions for alendronate)
  4. Referral to FLS (if not yet seen)
  5. GP follow-up instructions: review at 4 and 12 months, medication adherence, calcium/vitamin D, FRAX repeat
Give the patient (or carer):
  • Written information (Royal Osteoporosis Society leaflets - available at theros.org.uk)
  • Clear list of all new medications with instructions
  • Red flag symptoms to report: chest pain after alendronate, thigh/groin pain, jaw problems, new back pain
Tell the patient:
"Your GP will get a full letter about everything we've done. You should have a follow-up appointment with them within about 4 weeks to check how you're doing with the new medications. The fracture clinic/bone health clinic will also be in touch to do a bone scan (DXA) if we haven't done one already."

Summary Checklist for the Ward Doctor

Before discharge, confirm:
  • Secondary causes investigated (bloods including vitamin D, calcium, eGFR, TFTs)
  • Vitamin D deficiency corrected / calcium and vitamin D supplement prescribed
  • Bone protection medication initiated (alendronate, risedronate, OR zoledronate) OR documented reason for deferral/specialist referral
  • Renal function checked and drug dose/choice adjusted accordingly
  • DXA requested (inpatient or outpatient)
  • Falls risk medications reviewed and rationalised
  • Physiotherapy and occupational therapy referrals made
  • FLS referral made
  • Patients counselled verbally + written information given
  • Discharge summary documents osteoporosis diagnosis and plan clearly
  • GP follow-up arranged (4 weeks and 12 months)

Key Guidelines Referenced

so when doing capacity assement for discharge home, what are the questions to ask patient and document

Reading File
Searching the Web

mental capacity assessment discharge home hospital MCA 2005 questions documentation UK clinical practice

Finding Sources
Searching the Web

mental capacity assessment discharge destination "understand" "retain" "weigh" "communicate" questions to ask documentation template NHS

Reading Web Page

mental capacity assessment questions to ask discharge destination documentation four elements understand retain weigh communicate

Searching the Web

capacity assessment discharge home post hip fracture dementia "best interests" documentation ward UK example

I now have comprehensive information. Let me compile the full, practical guide.

Mental Capacity Assessment for Discharge Home: What to Ask and What to Document

The Legal Framework

This is governed by the Mental Capacity Act 2005 (MCA) - the law in England and Wales. The specific decision you are assessing is precisely defined:
"Does this patient have the capacity to decide where they will live/be discharged to?"
This is called a "residence capacity assessment" or "discharge destination capacity assessment." It is a different assessment from capacity to consent to surgery, capacity to refuse medication, etc. - capacity is always decision-specific.

The 5 Statutory Principles (MCA s.1) - Know These Before You Start

  1. A person must be assumed to have capacity unless established otherwise
  2. A person is not to be treated as lacking capacity unless all practicable steps to help them decide have been tried and failed
  3. A person is not lacking capacity just because they make an unwise decision
  4. Anything done or decided for a person lacking capacity must be done in their best interests
  5. Before acting, consider whether the purpose can be achieved in a less restrictive way

The Two-Stage Test

Stage 1: Is there an Impairment or Disturbance of the Mind or Brain?

This must exist. Common causes in post-hip fracture patients:
  • Dementia (Alzheimer's, vascular, Lewy body, mixed)
  • Delirium (very common post-operatively - and importantly, it may be temporary, so reassess)
  • Acquired brain injury
  • Severe depression
  • Severe learning disability
  • Effects of medication (sedatives, opioids)
  • Alcohol/substance intoxication
Document: "The patient has [diagnosis/condition] which is a disturbance/impairment of the mind or brain."
If there is no impairment at all, stop - the patient has capacity (by presumption). Do not conduct a capacity assessment on a patient with no suspected impairment.

Stage 2: Does That Impairment Mean the Patient Cannot Make This Decision?

A person cannot make a decision if they cannot do one or more of the following four things. These are the functional elements you assess and document for:

The Four Functional Elements: Questions to Ask

Before asking any questions, ensure optimal conditions:
  • Is this the best time of day? (dementia patients often have better cognition in the morning)
  • Is the environment calm, quiet, private?
  • Has delirium been treated and resolved as much as possible?
  • Does the patient need glasses or hearing aids?
  • Is a communication aid / interpreter / speech and language therapist needed?
  • Should you delay the assessment (e.g. wait for delirium to clear)?
Document whatever steps you took to optimise the assessment.

Element 1: Can They UNDERSTAND the Relevant Information?

First, give them the relevant information in simple, clear terms. For discharge home, the relevant information is:
"You have had a hip fracture and an operation. You are in hospital. We need to talk about where you will go when you leave hospital. You could go back home, or you could go to a care home, or you could go to a rehabilitation unit. At home, you would need help with [washing/dressing/cooking etc.]. There are risks if you go home - for example, the risk of falling again. There are also benefits - being in familiar surroundings, your independence. What do you understand about your situation?"
Questions to test understanding:
  • "Can you tell me in your own words why you are in hospital?"
  • "What happened to your hip/leg?"
  • "Do you understand that we are trying to decide where you will go when you leave hospital?"
  • "What are the options we've discussed for where you could go?"
  • "What does going home involve for you? What help would you need?"
  • "What would happen if you went home without any help?"
  • "Do you understand that your mobility has changed since before your fall?"
Document:
  • What information you provided to the patient (verbatim or paraphrased)
  • The patient's response in their own words
  • Whether they could understand and demonstrate comprehension of the key facts

Element 2: Can They RETAIN That Information?

This does not require long-term retention - just long enough to make the decision. You can legally use written notes, prompts, or aids to support retention.
Questions to test retention:
  • Ask the patient to repeat back the key points a few minutes after you explained them (re-ask without re-giving the information)
  • "Can you remind me - what are the options we discussed?"
  • "Earlier I explained the risks of going home without support - can you tell me what those were?"
  • "We talked about needing care at home - do you remember what kinds of help we said you'd need?"
Document:
  • How long after providing information you tested recall
  • Whether the patient could recall the key elements
  • If they could not - what specifically they could not retain

Element 3: Can They USE OR WEIGH the Information?

This is the most clinically important and often hardest to assess. It means the patient can balance the pros and cons, consider consequences, and use the information in their reasoning. A patient who can repeat back information but cannot reason about it may still lack capacity.
Questions to test use or weigh:
  • "What are the good things about going home?"
  • "What are the concerns or risks about going home?"
  • "What would make going home work? What would you need in place?"
  • "What would happen to you if you fell again at home?"
  • "What are the advantages and disadvantages of going to a care home / rehabilitation unit?"
  • "How are you weighing those things up - what matters most to you?"
  • "Why do you want to go home / to a care home?" (ask them to explain their reasoning, not just state a preference)
  • "If the care package fell through and there was no one to help you, what would you do?"
Watch for: Patients who state a preference ("I want to go home") without being able to explain any reasoning, weigh risks, or acknowledge the consequences of their choice. Preference alone is not the same as capacity.
Document:
  • The patient's reasoning in their own words
  • Whether they demonstrated understanding of consequences
  • Whether they could articulate pros and cons
  • If they could not weigh - describe specifically how their reasoning was impaired

Element 4: Can They COMMUNICATE Their Decision?

This includes any means: speech, writing, gestures, eye gaze, sign language, communication device.
Questions to test communication:
  • "So, having thought about everything, what is your decision about where you would like to go?"
  • If verbal communication is impaired: can they indicate yes/no with head nod? Point to written options? Use a picture board?
  • "Can you tell me clearly: do you want to go home, to a care home, or to a rehabilitation unit?"
Document:
  • The method of communication used
  • The decision as stated by the patient
  • If communication was not possible - what was tried and why it failed

What to Document - A Structured Template

The documentation should answer all of the following. Many trusts have an MCA proforma - use it. If not, write these elements clearly in the medical notes:

MENTAL CAPACITY ASSESSMENT
Date / Time: [date and time]
Assessor name and grade: [name, grade, bleep]
Others present: [family member, nurse, social worker, interpreter, etc.]

1. The specific decision being assessed: "Whether [patient name] has the capacity to decide their discharge destination / where they will live following this hospital admission."

2. Reason for the assessment: "Capacity is in question because [e.g. patient has known dementia / patient has post-operative delirium / patient is expressing a wish to return home that the MDT believe carries significant risk / there is disagreement between patient and family about discharge destination]."

3. Attempts to optimise capacity before assessment:
  • Did you conduct the assessment at the optimal time of day?
  • Was delirium investigated and managed?
  • Were sensory aids (glasses, hearing aids) in place?
  • Was the environment calm and private?
  • Was information given in simple, clear language?
  • Was an interpreter used?
  • Was an IMCA considered (if no family or friends to consult)?
  • Was the assessment timed to avoid medication side effects?
"The following steps were taken to optimise the patient's ability to make this decision: [list]"

4. Stage 1 - Diagnostic threshold: "[Patient] has [diagnosis] which constitutes an impairment/disturbance of the mind or brain."

5. Stage 2 - Functional elements:
Relevant information given to the patient: "I explained to [patient] that: they had a hip fracture and operation; they are preparing for discharge; the options are [home with care package / care home / rehabilitation unit]; the risks of each option; the support that would be available."
Understanding: "When asked to explain their situation in their own words, [patient] said: '[quote]'. They [did/did not] demonstrate understanding of [specific elements]. They were unable to understand [specific element] because [reason]."
Retention: "When asked approximately [X] minutes after being given information to recall the key points, [patient] [was/was not able to] recall [specific elements]. They stated: '[quote]'."
Use or weigh: "When asked about the pros and cons of each option, [patient] said: '[quote]'. They [demonstrated/did not demonstrate] the ability to reason about the risks and benefits. Specifically, [patient] [was/was not able to] acknowledge [e.g. the risk of falling at home] and could/could not factor this into their decision-making."
Communicate: "[Patient] communicated their decision by [speech/writing/gesture]. Their decision was: '[quote in patient's own words]'."

6. Conclusion: "In my assessment, [patient] [has/lacks] capacity to make this specific decision at this time."
If lacks capacity: state which element(s) they failed, and how this is caused by the impairment.
If capacity fluctuates: state this, note that the assessment should be repeated, and document when.

7. If capacity is LACKING - Best Interests decision:
A best interests decision must then be made. Key elements to document:
  • Who was consulted (family, carers, MDT, social worker)?
  • Does the patient have a Lasting Power of Attorney (LPA) for health and welfare? If so, that person makes the decision - not the doctor.
  • Does the patient have an Advance Care Plan or Advance Decision (ADRT)?
  • Has an IMCA (Independent Mental Capacity Advocate) been involved? (Required if the patient has no family/friends who can be consulted AND the decision involves serious medical treatment or a change in residence)
  • What are the patient's past and present wishes and feelings? (Prior expressed wishes, values, religious/cultural beliefs)
  • What would the patient have wanted if they had capacity?
  • Is the proposed plan the least restrictive option?
  • What is the proposed best interests decision and why?
Key point: Family members do not have the legal right to make decisions for an adult without capacity unless they hold a valid Health and Welfare LPA. They are consulted for their views on what the patient would want - but they are not decision makers in their own right.

Common Pitfalls to Avoid

PitfallWhat to do instead
Assessing capacity when delirium is still acuteTreat delirium first; reassess when clearer
Equating "making an unwise decision" with lacking capacityA patient can choose to go home against advice and still have capacity
Documenting "patient lacks capacity" without specifying the decisionAlways specify: "lacks capacity to decide X"
Letting family override a capacitous patient's decisionCapacitous patients can decide for themselves even against family wishes
Not documenting the patient's own wordsQuote the patient directly to evidence each element
Assuming incapacity because of a dementia diagnosisTest each element functionally - dementia does not automatically equal no capacity
Not exploring all communication optionsTry written options, picture boards, yes/no questions before concluding communication is impossible
Conflating social concerns with capacityA patient who is socially at risk but can understand and weigh the decision has capacity

Post-Hip Fracture Specific Points

  • Delirium affects up to 50% of hip fracture patients peri-operatively. It is often temporary - always reassess once delirium has resolved before making a definitive best interests decision about discharge
  • The "Discharge to Assess" model (NHS England 2023 guidance) says the default is to discharge home first with support and assess ongoing needs there - this reinforces that home is the presumed first option, not a last resort
  • If the patient wants to go home and has capacity to make that decision, that decision must be respected even if the MDT thinks it is risky
  • Where there is genuine uncertainty, the Social Work team and/or the Old Age Psychiatry liaison team can assist with the assessment
  • If there is a dispute between family/carers and the MDT about a patient lacking capacity and the best interests decision, this may ultimately need to go to the Court of Protection

this is dumb answer

Fair enough - tell me what was wrong with it so I can give you something actually useful.
Were you looking for:
  • The exact verbatim questions to ask the patient during the assessment (not the legal theory)?
  • A quick practical proforma/script you can use at the bedside?
  • Something more specific to discharge home after hip fracture rather than generic MCA stuff?
  • Something else entirely?
What would a good answer look like for you?

wheres the fire flood saftey question

Searching the Web

capacity assessment discharge home "fire flood" "intruder" questions UK ward hospital safety emergency response

Searching the Web

"capacity to return home" "what would you do if" fire flood intruder gas leak ward occupational therapy assessment questions

Good - found it. The fire/flood/intruder safety questions are a standard part of the OT-led "safe to return home" functional cognitive assessment, which sits alongside (and feeds into) the formal MCA capacity assessment. Let me give you the complete, practical picture now.

Capacity Assessment for Discharge Home: The Complete Practical Version

What You're Actually Assessing

There are two related but distinct assessments that happen together for discharge home - and confusing them is where the previous answer fell short:
  1. MCA capacity assessment - legal test under the Mental Capacity Act 2005 (the four functional elements)
  2. Functional safety assessment - practical "can they manage at home safely?" - this is where the fire/flood/intruder questions live
Both feed into the same decision: is it safe and appropriate to discharge this patient home?

The Safety Questions (What You Were Asking About)

These are hypothetical emergency scenario questions used to test whether the patient can recognise danger and respond appropriately. They are asked as part of the cognitive/functional assessment - usually led by OT or the ward team.
Ask them exactly like this:

Fire

"If you were at home and you smelled smoke or saw a fire, what would you do?"
Looking for: Get out of the house first, then call 999. NOT "put it out" or "wait for someone."

Flood / Gas leak

"If you came downstairs and found water flooding into your home / smelled gas, what would you do?"
Looking for: Leave the building, don't use switches or matches (gas), call for help (999 or a neighbour).

Intruder

"If you were at home at night and you heard someone trying to break in, what would you do?"
Looking for: Call 999, don't confront the intruder, stay safe. Some patients may say "call a family member" - that's acceptable as a first step if they follow up with 999.

Feeling unwell / medical emergency

"If you were at home and felt very unwell - for example, you fell and couldn't get up, or had a bad chest pain - what would you do?"
Looking for: Call 999 or use a personal alarm/telecare device if they have one. NOT "wait for someone to visit."

Medication

"How do you manage your tablets at home? What would you do if you weren't sure whether you'd taken them?"

How to Test It Practically (OT Method)

On some wards, OT will use an unplugged phone and simulate the call:
Patient says they would call 999 for a fire → hand them the phone → "Show me what you'd do" → patient dials 999 → you act as operator → "What service do you require?" → "What is the problem?" → "What is your address?"
That last question - "What is your address?" - is the critical one. Many patients with dementia or delirium can say "I'd call 999" but cannot recall their own address. If they cannot give their address in an emergency, they may not be able to summon help effectively even if they can physically dial.

The Full Practical Assessment at the Bedside

Combine both components like this:

Part 1: Orientation and Situational Awareness

  • "Can you tell me where you are right now?"
  • "Do you know what day/date it is today?"
  • "What happened to bring you into hospital?"
  • "Do you know what the plan is when you leave here?"

Part 2: Understanding Their Home Situation

  • "Where do you live? Can you tell me your address?"
  • "Do you live alone or with someone?"
  • "Who usually helps you at home?"
  • "What do you normally manage by yourself - cooking, washing, getting dressed?"
  • "How do you normally get around the house? Do you use a walking stick/frame?"

Part 3: Safety Scenario Questions

  • Fire: "What would you do if there was a fire at home?"
  • Medical emergency: "What would you do if you fell and couldn't get up?"
  • Intruder: "What would you do if someone tried to break in?"
  • Feeling very unwell: "What would you do if you felt very ill and needed urgent help?"
  • Medications: "How do you manage your medications? What if you weren't sure if you'd taken them?"

Part 4: MCA Functional Elements (weigh up the discharge decision)

  • "Do you understand that your mobility has changed since your fall?"
  • "What do you think you can and can't do for yourself at home now?"
  • "What are the risks of going home at the moment?"
  • "What support do you think you'd need?"
  • "What would you do if the care package wasn't in place?"

What to Document

For each safety scenario, document the patient's actual answer in their own words, e.g.:
"When asked what they would do in a house fire, patient stated: 'I'd ring 999'. When asked what their address was, patient was unable to recall their home address despite prompting."
"Patient correctly identified they would leave the house and call 999 in a fire. Patient was able to state their address accurately."
"Patient stated they would 'wait for my daughter' if they fell at home. When asked what they would do if their daughter was not available, patient was unable to generate an alternative plan."
This directly feeds into the MCA "use or weigh" element - a patient who cannot generate a safe response to an emergency at home may not be able to weigh the risks of the discharge decision adequately.

The Key Insight

The fire/flood/intruder questions test the "use or weigh" element of the MCA in a concrete, practical way. They test:
  • Can the patient recognise danger?
  • Can they generate an appropriate response?
  • Can they access help (know their address, use a phone)?
If a patient says "I'd call 999 for a fire" but cannot state their own address - that is a significant finding that should be documented and factored into both the safety assessment and the capacity decision.
This is a shared conversation. Sign in to Orris to start your own chat.